Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma.
D000293:Adolescent; D000328:Adult; D001344:Autopsy; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use* / Q000633:toxicity; D008937:Mitomycins / Q000627:therapeutic use* / Q000633:toxicity; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000188:drug therapy*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use* / Q000633:toxicity
D008937:Mitomycins; D014750:Vincristine; D008558:Melphalan